HomeCGTX • NASDAQ
add
Cognition Therapeutics Inc
Previous close
$1.75
Day range
$1.70 - $1.75
Year range
$0.22 - $3.83
Market cap
153.60M USD
Avg Volume
1.03M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 6.38M | -55.92% |
Net income | -4.93M | 50.39% |
Net profit margin | — | — |
Earnings per share | -0.06 | 76.00% |
EBITDA | -6.36M | 55.94% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 39.33M | 78.70% |
Total assets | 43.40M | 57.35% |
Total liabilities | 6.87M | -47.58% |
Total equity | 36.53M | — |
Shares outstanding | 88.27M | — |
Price to book | 4.27 | — |
Return on assets | -50.58% | — |
Return on capital | -71.78% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -4.93M | 50.39% |
Cash from operations | -5.65M | 17.52% |
Cash from investing | — | — |
Cash from financing | 33.92M | 10,209.12% |
Net change in cash | 28.27M | 533.39% |
Free cash flow | -4.28M | 27.54% |
About
Founded
Jan 1, 2007
Website
Employees
25
